Biological degradable nano medicinal capsule with MRI tracer effect and its preparing method
A technology of biodegradation and nano-medicine, applied in the direction of medical preparations containing active ingredients, capsule delivery, pharmaceutical formulations, etc., can solve the problems of single imaging parameters and inflexibility, and achieve simple process, high drug loading, and production equipment less demanding effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0063] Get the aqueous solution of 3.5% (w / v) polyethylene glycol PEG of 3ml as inner aqueous phase (being dispersion system A), 30mg ovalbumin and 0.8mgNMG2 [Gd-DTPA · H O] (trade name Magnevist) are dispersed in In water; the organic phase (i.e. dispersion system B) is 6ml methylene chloride dissolved with 2.5% (w / v) PLGA; the external aqueous phase (i.e. dispersion system C) is 0.4% (w / v) PEG54ml aqueous solution which is stirred and dissolved . Add the inner water phase to the organic phase and disperse it evenly in a homogenizer (9500rpm), then add it to the outer water phase to disperse, at a temperature of 23°C and a pressure of 1.01×10 5 Under Pascal conditions, stir until the organic phase is completely evaporated, PLGA precipitates and solidifies into balls, and ovalbumin and NMG2[Gd-DTPA·H2O] (trade name Magnevist) are coated inside to form a core / shell structure drug-loaded nanocapsules.
Embodiment 2
[0065] Get the aqueous solution of 4.5% (w / v) polyvinyl alcohol PVA of 3ml as internal water phase, 45 milligrams of doxorubicin and 1.2mg NMG2 [Gd-DTPA · H O] (trade name Magnevist) are dispersed in water; There are 6ml of acetone with 6% (w / v) PLA; the external aqueous phase is 65ml aqueous solution of 0.5% (w / v) PVA dissolved by stirring. Add the inner water phase to the organic phase and disperse it evenly in the disperser (9500rpm), and then add it to the outer water phase to disperse. 5 Under the condition of Pascal, stirring and evaporating for about 180 minutes to remove the organic phase, PLA precipitated and solidified into spheres, and doxorubicin and NMG2[Gd-DTPA·H2O] (trade name Magnevist) were coated inside to form a core / shell structure. drug nanocapsules.
Embodiment 3
[0067] Get 6ml of 5% (w / v) sodium dodecylsulfonate aqueous solution as the inner water phase, 30 mg paclitaxel and 1.5 mg NMG [Gd-DTPA H O] (trade name Magnevist) are dispersed in water; the organic phase is 6 ml of dichloromethane dissolved with 10% (w / v) PLGA; the external aqueous phase is 54 ml of 0.4% (w / v) PVA aqueous solution dissolved by stirring. Add the inner water phase to the organic phase and disperse it evenly in a mixer (9500rpm), then add it to the outer water phase to disperse, at a temperature of 26°C and a pressure of 1.01×10 5 Pa, stirred and evaporated for about 240 minutes to remove the organic phase, PLGA precipitated and solidified into balls, and paclitaxel and NMG2[Gd-DTPA·H2O] (trade name Magnevist) were coated inside to form drug-loaded nanocapsules with a core / shell structure.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com